Organon & Co. (OGN) Stock Profile — Insider Trades & Financials

Revenue$1.5B

Net Income-$205.0M

EPS$0.72

Gross Margin49.2%

Market Cap$1.6B

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

Joseph Morrissey

CEO & Executive Director

Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.

Founded: 1923
Employees: 10,000
Headquarters: JERSEY CITY, NJ, United States
Website: www.organon.com

⚡

Core Efficiency

ROE?

-27.26%

ROA?

-1.59%

D/E Ratio?

16.11

📊

Profitability Ratios

Net Margin?

-13.60%

Current Ratio?

1.82

Loading company sections...

Organon & Co.

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness